Nicolas Girard

Université Claude Bernard Lyon 1

Papers

2

Total Citations

199

H-Index

2

About

Nicolas Girard is a leading figure in thoracic oncology, with a specialized focus on the diagnosis and management of thymomas—rare intrathoracic malignant tumors. His seminal work, particularly a highly cited 2009 paper on current therapeutic management, has shaped clinical understanding of these complex neoplasms. Girard’s contributions emphasize the critical role of the Masaoka staging system, which relies on peroperative and histopathological findings to guide treatment. He has championed surgery as the cornerstone of thymoma management, highlighting its dual utility in achieving precise histopathological diagnosis and accurate staging. With over 196 citations for his landmark review, Girard’s research has provided a foundational framework for clinicians navigating the therapeutic challenges of thymomas. His work underscores the importance of multidisciplinary approaches in rare cancers, bridging surgical oncology and pathology to improve patient outcomes. For students and researchers, Girard’s scholarship offers a clear, evidence-based roadmap for understanding and treating these uncommon tumors, cementing his reputation as a key authority in the field.

Research Focus

Key Achievements

2
H-Index
2
Papers
199
Total Citations
100
Avg Citations/Paper
🏆 Most Cited Paper
Thymoma: A Focus on Current Therapeutic Management
196 citations · 2009
📈 Most Prolific Year: 2009 (2 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Université Claude Bernard Lyon 1

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago